Institutional Ownership Xilio Therapeutics, Inc. (XLO)
This table provides information about the institutional ownership of Xilio Therapeutics, Inc. (XLO). We have compiled data on the 34 institutions that hold shares in the stock, with a total of 14 Million shares, which have been reported (via 13F filing form) to have a value of $12.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
10,389
shares
|
$9,142
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Dunhill Financial, LLC
London, X0 |
Nov 15, 2024 Q3 2024 |
10,274
shares
|
$9,041
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Pinnacle Financial Group, LLC
|
Nov 12, 2024 Q3 2024 |
10,000
shares
|
$8,800
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
5,616
shares
|
$4,942
0.0% of portfolio
|
Q3 2024
Added 33.49%
|
|
|
Key F Inancial Inc
|
Oct 29, 2024 Q3 2024 |
830
shares
|
$730
0.0% of portfolio
|
Q1 2023
New holding
|
|
|
Private Wealth Management Group, LLC
Princeton, NJ |
Oct 29, 2024 Q3 2024 |
310
shares
|
$272
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
266
shares
|
$234
0.0% of portfolio
|
Q3 2024
Reduced 61.56%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
75
shares
|
$66
0.0% of portfolio
|
Q3 2024
Added 27.12%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|